Product Information
RUFINAMIDE 40 MG/ML SUSPENSION is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2262 per ML under NDC 68180079701. Its NADAC has been published 131 times since Dec 27, 2023.
Strength
40 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180079701
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213457On Market Since
6/22/2023
Price Statistics
The NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has been published 131 times since Dec 27, 2023, and over the history we have for it it has declined 65.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2262 per ML |
|---|---|
| All-time high | $0.7738 (Apr 10, 2024) |
| All-time low | $0.2262 (Jun 17, 2026) |
| 52-week high | $0.3887 |
| 52-week low | $0.2262 |
| Median price | $0.3445 |
| Average price | $0.4010 |
| Largest weekly change | +45.9% (Sep 18, 2024) |
| Weeks tracked | 131 |
| Tracking since | Dec 27, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RUFINAMIDE 40 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 40 MG/ML SUSPENSION, manufactured by Lupin Pharmaceuticals Inc., is $0.2262 per ML (NDC 68180079701), effective Jun 24, 2026.
How has the price of RUFINAMIDE 40 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has declined 65.3%. It has been tracked across 131 weekly CMS publications since Dec 27, 2023.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 40 MG/ML SUSPENSION?
Since Dec 27, 2023, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has ranged from a low of $0.2262 (Jun 17, 2026) to a high of $0.7738 (Apr 10, 2024), with a median of $0.3445 per ML.
Are there cheaper alternatives to RUFINAMIDE 40 MG/ML SUSPENSION?
6 NADAC-published products share the same active ingredient, strength, and dosage form as RUFINAMIDE 40 MG/ML SUSPENSION, but none are currently priced below it.
Who manufactures RUFINAMIDE 40 MG/ML SUSPENSION?
RUFINAMIDE 40 MG/ML SUSPENSION (NDC 68180079701) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification